Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

ClinicalTrials.gov ID: NCT01283594

Public ClinicalTrials.gov record NCT01283594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 4:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of SYN115 as Adjunctive Therapy in Levodopa-treated Parkinson's Subjects With End of Dose Wearing Off

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to test the effect of SYN115 compared to placebo (a "sugar pill" that looks like SYN115 but does not include active drug) on movement during the "on" and "off" states as well as other symptoms that some patients with Parkinson's disease experience. This study will also look at whether or not patients with Parkinson's disease experience "side-effects" with SYN115.

Study identification

NCT ID
NCT01283594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Biotie Therapies Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Oct 2012 (Actual)
Last update posted
Jan 17, 2019

2011 – 2012

United States locations

U.S. sites
40
U.S. states
24
U.S. cities
40
Facility City State ZIP Site status
Not listed Birmingham Alabama 35005 —
Not listed La Jolla California 92037 —
Not listed Loma Linda California 92318 —
Not listed Los Angeles California 90001 —
Not listed Oxnard California 93030 —
Not listed San Francisco California 94016 —
Not listed Denver Colorado 80014 —
Not listed Manchester Connecticut 06040 —
Not listed New Haven Connecticut 06501 —
Not listed Boca Raton Florida 33427 —
Not listed Gainesville Florida 32601 —
Not listed Miami Florida 33101 —
Not listed Tampa Florida 33601 —
Not listed Weston Florida 33326 —
Not listed Atlanta Georgia 30301 —
Not listed Augusta Georgia 30901 —
Not listed Boise Idaho 83701 —
Not listed Springfield Illinois 62629 —
Not listed Indianapolis Indiana 46077 —
Not listed Des Moines Iowa 50047 —
Not listed Kansas City Kansas 66012 —
Not listed Lexington Kentucky 40502 —
Not listed Baltimore Maryland 21201 —
Not listed West Bloomfield Michigan 48302 —
Not listed Minneapolis Minnesota 55111 —
Not listed Commack New York 11725 —
Not listed New York New York 10001 —
Not listed Durham North Carolina 27517 —
Not listed Cincinnati Ohio 41073 —
Not listed Cleveland Ohio 44101 —
Not listed Columbus Ohio 43004 —
Not listed Toledo Ohio 43460 —
Not listed Tulsa Oklahoma 74008 —
Not listed Allentown Pennsylvania 18001 —
Not listed Philadelphia Pennsylvania 19019 —
Not listed Charleston South Carolina 29401 —
Not listed Dallas Texas 75001 —
Not listed Houston Texas 77001 —
Not listed Roanoke Virginia 24001 —
Not listed Milwaukee Wisconsin 53201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01283594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01283594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →